The reamer–irrigator–asiprator (RIA): a systematic review  by Cox, George et al.
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Methods: Aspiration of the IM cavities of 5 patients’ femurs
ith matched ICBMA was performed. The long-bone-fatty-bone-
arrow (LBFBM) aspirated was ﬁltered (70m) and the solid
raction digested for 60min (37 ◦C) with collagenase. MSCs
ere isolated from LBFBM-liquid/LBFBM-solid fractions and from
atched ICBMA. Enumeration of MSCs was achieved via colony-
orming-unit-ﬁbroblast (CFU-F) assay and ﬂow-cytometry on
resh sample using CD45low CD271+. MSCs were cultured by
irtue of their plastic adherence and passaged in standard, non-
aematopoietic media. Passaged (P2) cells were differentiated
owards osteogenic, adipogenic and chondrogenic lineages with
heir phenotype assessed using ﬂow-cytometry CD33, CD34, CD45,
D73, CD90, CD105.
Results: MSCs were isolated from all fractions. Using the CFU-F
ssay median number of colonies: ICBMA=8 (2–21), LBFBM-
iquid =14 (0–53), LBFBM-solid =116 (23–171)per200l of sample
ith MSC frequency, as percentage of total cells, using ﬂow-
ytometry, providing similar results.MSCs isolated from the LBFBM
hases appeared to be not inferior to ICBMA in terms of osteogenic,
hondrogenic or adipogenic differentiation. Passaged cells from all
ractions had a phenotype consistent with other reported sources.
Discussion: The IM cavity of the femur is a depot of MSCs
hich are closely associated with fat but are at least equiva-
ent to ICBMA in terms of osteogenic/chondrogenic differentiation.
ntramedullary cavities of long-bones are frequently accessed by
he orthopaedic/trauma surgeon and reaming/removal of IM con-
ents is necessary for the nailing/insertion of prostheses. Removal
f the LBFBM prior to standard reaming, using a syringe and suc-
ion tubing, is a ‘low-tech’ method of harvesting LBFBM that can be
rieﬂy digested to give high yields of MSC. The volumetric concen-
ration of MSCs within this fraction is signiﬁcantly higher than that
or ICBM (∼10 fold) and we postulate that this would aid its use as
n alternative for autologous/allogenous use.
Conclusion: High concentrations ofMSC can be achieved by brief
igestion of aspirated IM fat from the femur. These cells appear
ppropriate for orthopaedic applications.
oi:10.1016/j.injury.2010.07.470
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Background: The ‘reamer–irrigator–aspirator’ (RIA) is an inno-
ation developed to reduce fat embolism (FE) and thermal necrosis
TN) that can occur during reaming/nailing of long-bone fractures.
ince its inception its indications have expanded to include the
reatment of post-operative osteomyelitis and as a harvester of
one-graft/mesenchymal-stem-cells (MSCs).
Purpose: To review the sources reporting on this device and
omment on its effectiveness to (1) prevent FE and TN; (2) treat
ost-operative osteomyelitis; (3) harvest bone-graft andMSCs; and
4) operate safely.1 (2010) 131–166
Methods: A systematic review via pubmed and google scholar
using the keywords ‘reamer’, ‘irrigator’ and ‘aspirator’.
Results: Experimental data supports the use of the RIA in pre-
venting FE and TN, however, there is a paucity of clinical data.
The RIA is a reliable method in achieving high volumes of bone-
graft and MSCs. High union rates are reported when using RIA
bone-fragments to treat non-unions, however, papers are subject
to confounding factors. Evidence suggests possible effectiveness in
treating post-operative ostemyelitis. The RIA appears safe, with a
low rate of morbidity provided a meticulous technique is used.
Conclusions: Current evidence suggests that the RIA is safe to
use and effective in (1) preventing FE and TN; (2) treating post-
operative osteomyelitis; (3) harvesting bone-graft and MSCs. This
RIA demands further investigation especially with respect to the
optimal application of MSCs for bone repair strategies.
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Introduction: There are currently two prognostic tools available
for predicting outcome in traumatic brain injury (TBI). The ﬁrst
involves prognostic models combining clinico-demographic char-
acteristics of patients for outcome prediction, whilst the second
employs serumbrain injurybiomarkers. S100B is awidelyacknowl-
edged biomarker of brain injury.
Objective: To identify which method has better prognostic
strengthandexplorehowcombining thesemethodsmight improve
the prognostic strength.
Methods: We analysed data from 100 TBI patients, all of whom
were admitted to the intensive care unit and had venous S100B
levels recorded at 24-h after injury. TBI prognostic models A and B,
constructed in Trauma Audit and Research Network (TARN), were
run on the dataset and then S100B was added as an independent
predictor to each model. Furthermore, another model was devel-
oped containing only S100B and subsequently, other important TBI
predictors were added to assess their ability to enhance the predic-
tive power of this model. The outcome measures were survival and
favourable outcome at 3 months.
Results: Among all the prognostic variables (including age, cause
of injury,GCS, pupillary reactivity, Injury Severity Score (ISS) andCT
classiﬁcations); S100Bhas thehighest predictive strengthonmulti-
variate analysis. No difference between performance of prognostic
models or S100B in isolation was observed. Addition of S100B to
the prognostic models improves the performance (e.g. Area Under
